THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF EBMT / Eder, S.; Labopin, M.; Arcese, W.; Or, R.; Majolino, I.; Bacigalupo, A.; DE ROSA, Gennaro; Volin, L.; Beelen, D.; Veelken, H.; Schaap, N.; Kuball, J.; Cornelissen, J.; Nagler, A.; Mohty, M.. - In: BLOOD. - ISSN 0006-4971. - (2013).
THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF EBMT
DE ROSA, GENNARO;
2013
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
